全体要約
関連する質問
0.5 billion USD (2023)
32.3% (2023-2028)
NVIDIA Corporation, Microsoft Corporation, Google, Inc., Intel Corporation, BenevolentAI, SOPHiA GENETICS, Illumina, Inc., Predictive Oncology, Inc., Invitae Corporation, Deep Genomics, Inc., Fabric Genomics, Inc., Verge Genomics, Freenome Holdings, Inc., MolecularMatch, Inc., Dante labs, Data4Cure, PrecisionLife Ltd, Genoox, Lifebit, FDNA, Inc., DNAnexus, Engine Biosciences, Tempus Labs, Inc., Congenica Ltd, Emedgene, Inc., Seragon Pharmaceuticals, Inc.
プロセスとタイムラインの加速, 医薬品開発と発見のコスト削減, AIソリューションによる染色体障害の特定
概要
目次
Description
Table of Contents
